Phase III Randomized Controlled Study of Postoperative Adjuvant Therapy Using TS-1 [S-1] or TS-1+PSK [polysaccharide K] for Stage II or III Gastric Cancer Patients.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 21 Mar 2012
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Polysaccharide K (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 21 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Jun 2008 New trial record.